| | Variables | Inactive | LPA | MVPA | LPA + MVPA | Overall | | (n = 27,800) | (n = 15,862) | (n = 6,643) | (n = 22,694) | (n = 72,999) |
| | Age (years) | 69.7 ± 12 | 69.0 ± 10 | 69.2 ± 9 | 69.6 ± 8 | 69.5 ± 10 | | Sex (men) | 9,772 ± 35 | 5,270 ± 33 | 2,727 ± 41 | 10,544 ± 47 | 28,313 ± 39 | | Body mass index (kg/m2) | 23.0 ± 3.5 | 22.8 ± 3.4 | 23.1 ± 3.2 | 22.9 ± 3.1 | 22.9 ± 3.3 | | Systolic blood pressure (mmHg) | 129 ± 17 | 129 ± 17 | 129 ± 17 | 129 ± 16 | 129 ± 17 | | Diastolic blood pressure (mmHg) | 75 ± 11 | 75 ± 10 | 75 ± 10 | 75 ± 10 | 75 ± 11 | | Current smoking (yes) | 3,646 ± 13 | 2,115 ± 13 | 771 ± 12 | 2,701 ± 12 | 9,233 ± 13 | | Diabetes mellitus (yes) | 3,561 ± 13 | 1,835 ± 12 | 958 ± 14 | 3,164 ± 14 | 9,518 ± 13 | | History of coronary disease (yes) | 3,659 ± 13 | 1,882 ± 12 | 796 ± 12 | 2,564 ± 11 | 8,901 ± 12 | | History of stroke (yes) | 2,341 ± 8 | 946 ± 6 | 430 ± 7 | 1,328 ± 6 | 5,045 ± 7 | | Treatment of hypertension (yes) | 11,730 ± 42 | 6,634 ± 42 | 2,706 ± 41 | 9,441 ± 42 | 30,511 ± 42 | | eGFR (mL/min/1.73 m2) | 72 ± 18 | 73 ± 16 | 71 ± 15 | 72 ± 15 | 72 ± 16 | | Proteinuria (≥1+) | 2,140 ± 8 | 1,130 ± 7 | 473 ± 7 | 1,466 ± 7 | 5,209 ± 7 | | Hemoglobin (g/dL) | 13.3 ± 1.5 | 13.3 ± 1.4 | 13.5 ± 1.4 | 13.5 ± 1.4 | 13.4 ± 1.5 | | HbA1c (%) | 5.7 (5.4, 5.9) | 5.7 (5.4, 5.9) | 5.8 (5.4, 5.9) | 5.7 (5.4, 5.9) | 5.7 (5.4, 5.9) | | Total cholesterol (mg/dL) | 204 ± 35 | 205 ± 35 | 205 ± 34 | 204 ± 34 | 204 ± 35 | | Follow-up period (years) | 5.6 ± 3 | 5.9 ± 3 | 6.1 ± 3 | 6.3 ± 3 | 5.9 ± 3 |
|
|
Note: Data are presented in numbers (%), mean ± standard deviation, or median (25th and 75th percentiles). LPA, regular light-intensity physical activity; MVPA, occasional moderate-to-vigorous physical activity; eGFR, estimated glomerular filtration rate.
|
